Documenting his experiences has proven to be the outlet Darin Nakakihara needs in the wake of his ALS diagnosis.

Shares of Klotho Neurosciences, Inc. (NASDAQ:KLTO) surged 22% following news that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s gene therapy ...

Commonly prescribed medications for anxiety, depression and sleep disorders may be associated with a higher risk of ...

BrainStorm Cell Therapeutics issued a statement Tuesday supporting a Citizens’ Petition submitted to the FDA requesting the ...

Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

Neurizon Therapeutics has entered into a global licensing deal with Elanco Animal Health to advance the development of NUZ-001 for ALS.

Doctors implanted a microchip into a paralyzed patient's brain as part of a clinical trial giving people the ability to ...

The amount of lives that he touched and changed for the better number in the thousands," his stepdaughter wrote.

Unlike other interfaces—which sound stiff and robotic, like early smart assistants—this one imitates the sound and cadence of ...

Explore Our Free-Market Analysis Sample – Instant Access: – https://www.astuteanalytica.com/request-sample/amyotrophic-lateral-sclerosis-treatment-market ...